For example, HspB5-deficient mice show an increased lesion size after experimental stroke (middle cerebral artery occlusion, MCAO), an effect which could be reversed by intraperitoneal injection of recombinant HspB5 (Arac et al. 2011). Here, CRYAB is linked to stroke disorder.